# RADIOSA (NCT03940235)

> Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsis

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03940235
- Phase: PHASE2
- Status: UNKNOWN
- Sponsor: European Institute of Oncology
- Conditions: Oligometastatic Prostate Cancer
- Interventions: Androgen deprivation therapy (ADT); SBRT
- Enrollment: 150
- Primary outcome: Progression-free survival (PFS)

## Commentary we found

- X threads: 39
- YouTube: 4
- Podcasts: 2

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=radiosa-nct03940235

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03940235", "email": "<work email>"}; the inbox owner confirms by the emailed link.